Cargando…

Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer

Marine seaweeds are important sources of drugs with several pharmacological characteristics. The present study aims to evaluate the antitumor and antitumor immunological potentials of the extracts from the brown alga Padina pavonica and the red alga Jania rubens, inhibiting the Egyptian marine coast...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sheekh, Mostafa M., Nassef, Mohamed, Bases, Eman, Shafay, Shimaa El, El-shenody, Rania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396856/
https://www.ncbi.nlm.nih.gov/pubmed/35999584
http://dx.doi.org/10.1186/s12935-022-02683-y
_version_ 1784772011751374848
author El-Sheekh, Mostafa M.
Nassef, Mohamed
Bases, Eman
Shafay, Shimaa El
El-shenody, Rania
author_facet El-Sheekh, Mostafa M.
Nassef, Mohamed
Bases, Eman
Shafay, Shimaa El
El-shenody, Rania
author_sort El-Sheekh, Mostafa M.
collection PubMed
description Marine seaweeds are important sources of drugs with several pharmacological characteristics. The present study aims to evaluate the antitumor and antitumor immunological potentials of the extracts from the brown alga Padina pavonica and the red alga Jania rubens, inhibiting the Egyptian marine coasts. Hep-G2 cell lines were used for assessment of the antitumor efficacy of Padina pavonica and Jania rubens extracts in vitro, while Ehrlich ascites carcinoma (EAC) cells were applied to gain more antitumor immunity and antitumor insights of P. pavonica and J. rubens extracts in vivo. In vitro antitumor potentials of P. pavonica and J. rubens extracts were analyzed against human liver cancer Hep-G2 cells by MTT and trypan blue exclusion assays. In vivo antitumor immunological potentials of P. pavonica and J. rubens extracts at low, high, and prophylactic doses were analyzed by blood counting and flow cytometry in mice challenged with Ehrlich ascites carcinoma (EAC) cells. In vitro results revealed that P. pavonica and J. rubens extracts caused significant decreases in the number and viability of Hep-G2 cells in a dose-dependent manner as compared to untreated Hep-G2 cells or Cisplatin(®)-treated Hep-G2 cells. In vivo findings showed that P. pavonica and J. rubens extracts at low, high, and prophylactic doses significantly reduced the number and viability of EAC tumor cells accompanied by increases in EAC apoptosis compared to naïve EAC mouse. Additionally, P. pavonica and J. rubens extracts at low and prophylactic doses remarkably increased both the total WBC count and the relative numbers of lymphocytes and decreased the relative numbers of neutrophils and monocytes. Flow cytometric analysis showed that P. pavonica and J. rubens extracts at the treatment and the prophylactic doses resulted in a significant increase in the phenotypic expressions of CD4(+) T, CD8(+) T, and CD335 cells compared to naïve EAC mouse. Overall, both extracts P. pavonica and J. rubens possess potential antitumor and antitumor immunological effects with less toxicity, opening new approaches for further studies of the chemical and biological mechanisms behind these effects.
format Online
Article
Text
id pubmed-9396856
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93968562022-08-24 Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer El-Sheekh, Mostafa M. Nassef, Mohamed Bases, Eman Shafay, Shimaa El El-shenody, Rania Cancer Cell Int Research Marine seaweeds are important sources of drugs with several pharmacological characteristics. The present study aims to evaluate the antitumor and antitumor immunological potentials of the extracts from the brown alga Padina pavonica and the red alga Jania rubens, inhibiting the Egyptian marine coasts. Hep-G2 cell lines were used for assessment of the antitumor efficacy of Padina pavonica and Jania rubens extracts in vitro, while Ehrlich ascites carcinoma (EAC) cells were applied to gain more antitumor immunity and antitumor insights of P. pavonica and J. rubens extracts in vivo. In vitro antitumor potentials of P. pavonica and J. rubens extracts were analyzed against human liver cancer Hep-G2 cells by MTT and trypan blue exclusion assays. In vivo antitumor immunological potentials of P. pavonica and J. rubens extracts at low, high, and prophylactic doses were analyzed by blood counting and flow cytometry in mice challenged with Ehrlich ascites carcinoma (EAC) cells. In vitro results revealed that P. pavonica and J. rubens extracts caused significant decreases in the number and viability of Hep-G2 cells in a dose-dependent manner as compared to untreated Hep-G2 cells or Cisplatin(®)-treated Hep-G2 cells. In vivo findings showed that P. pavonica and J. rubens extracts at low, high, and prophylactic doses significantly reduced the number and viability of EAC tumor cells accompanied by increases in EAC apoptosis compared to naïve EAC mouse. Additionally, P. pavonica and J. rubens extracts at low and prophylactic doses remarkably increased both the total WBC count and the relative numbers of lymphocytes and decreased the relative numbers of neutrophils and monocytes. Flow cytometric analysis showed that P. pavonica and J. rubens extracts at the treatment and the prophylactic doses resulted in a significant increase in the phenotypic expressions of CD4(+) T, CD8(+) T, and CD335 cells compared to naïve EAC mouse. Overall, both extracts P. pavonica and J. rubens possess potential antitumor and antitumor immunological effects with less toxicity, opening new approaches for further studies of the chemical and biological mechanisms behind these effects. BioMed Central 2022-08-23 /pmc/articles/PMC9396856/ /pubmed/35999584 http://dx.doi.org/10.1186/s12935-022-02683-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
El-Sheekh, Mostafa M.
Nassef, Mohamed
Bases, Eman
Shafay, Shimaa El
El-shenody, Rania
Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title_full Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title_fullStr Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title_full_unstemmed Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title_short Antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
title_sort antitumor immunity and therapeutic properties of marine seaweeds-derived extracts in the treatment of cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396856/
https://www.ncbi.nlm.nih.gov/pubmed/35999584
http://dx.doi.org/10.1186/s12935-022-02683-y
work_keys_str_mv AT elsheekhmostafam antitumorimmunityandtherapeuticpropertiesofmarineseaweedsderivedextractsinthetreatmentofcancer
AT nassefmohamed antitumorimmunityandtherapeuticpropertiesofmarineseaweedsderivedextractsinthetreatmentofcancer
AT baseseman antitumorimmunityandtherapeuticpropertiesofmarineseaweedsderivedextractsinthetreatmentofcancer
AT shafayshimaael antitumorimmunityandtherapeuticpropertiesofmarineseaweedsderivedextractsinthetreatmentofcancer
AT elshenodyrania antitumorimmunityandtherapeuticpropertiesofmarineseaweedsderivedextractsinthetreatmentofcancer